Few topics in dermatology spark more debate than the sexual side effects of oral finasteride. In this episode of Skin in the Game, we break down the latest evidence comparing finasteride and dutasteride, including a new pharmacovigilance analysis, and discuss what these data can—and can’t—tell us about real-world risk.

We explore the strengths and limitations of adverse event databases, the role of reporting bias and the nocebo effect, and how to counsel patients using the best available evidence. Finally, we discuss whether dutasteride truly differs from finasteride and what these findings mean for everyday clinical practice.

Join us as we separate myth from evidence and provide practical, evidence-based takeaways for clinicians treating patients with androgenetic alopecia.

Skin in the Game delivers high-yield dermatology quick hits for busy clinicians.

Hosted by:
• Graham Litchman, DO, MS — Vivida Dermatology, Las Vegas, NV
• Diego Ruiz Dasilva, MD — Forefront Dermatology, Virginia Beach, VA

We read the research so you don’t have to.

For show notes and more information please visit our website at https://skininthegamepodcast.buzzsprout.com/

Disclaimer: This podcast is intended for educational purposes only and does not constitute medical advice. Views expressed are those of the hosts and do not necessarily reflect those of their employers or affiliated organizations.